Studies conducted in primary care as well as in psychiatric settings show that more than half of patients sufering from major depressive disorder (MDD) have poor adherence to antidepressants. Patients prematurely discontinue antidepressant therapy for various reasons, including patient-related (e.g., misperceptions about antidepressants, sideefects, and lack of tolerability), clinician-related (e.g., insufcient instruction received by clinicians about the medication, lack of shared decision-making, and follow-up care), as well as structural factors (e.g., access, cost, and stigma). The high rate of poor adherence to antidepressant treatments provides the impetus for identifying factors that are contributing to noncompliance in an individual patient, to implement a careful education about this phenomenon. As adherence to antidepressants is one of the major unmet needs in MDD treatment, being associated with negative outcomes, we sought to identify a series of priorities to be discussed with persons with MDD with the larger aim to improve treatment adherence. To do so, we analyzed a series of epidemiological fndings and clinical reasons for this phenomenon, and then proceeded to defne through a multi-step consensus a set of recommendations to be provided by psychiatrists and other practitioners at the time of the frst (prescription) visit with patients. Herein, we report the results of this initiative.

How to improve adherence to antidepressant treatments in patients with major depression: a psychoeducational consensus checklist

Maria Giulia Nanni;
2020

Abstract

Studies conducted in primary care as well as in psychiatric settings show that more than half of patients sufering from major depressive disorder (MDD) have poor adherence to antidepressants. Patients prematurely discontinue antidepressant therapy for various reasons, including patient-related (e.g., misperceptions about antidepressants, sideefects, and lack of tolerability), clinician-related (e.g., insufcient instruction received by clinicians about the medication, lack of shared decision-making, and follow-up care), as well as structural factors (e.g., access, cost, and stigma). The high rate of poor adherence to antidepressant treatments provides the impetus for identifying factors that are contributing to noncompliance in an individual patient, to implement a careful education about this phenomenon. As adherence to antidepressants is one of the major unmet needs in MDD treatment, being associated with negative outcomes, we sought to identify a series of priorities to be discussed with persons with MDD with the larger aim to improve treatment adherence. To do so, we analyzed a series of epidemiological fndings and clinical reasons for this phenomenon, and then proceeded to defne through a multi-step consensus a set of recommendations to be provided by psychiatrists and other practitioners at the time of the frst (prescription) visit with patients. Herein, we report the results of this initiative.
2020
Dell’Osso, Bernardo; Albert, Umberto; Carrà, Giuseppe; Pompili, Maurizio; Nanni, Maria Giulia; Pasquini, Massimo; Poloni, Nicola; Raballo, Andrea; Sambataro, Fabio; Serafini, Gianluca; Viganò, Caterina; Demyttenaere, Koen; Mcintyre, Roger S.; Fiorillo, Andrea
File in questo prodotto:
File Dimensione Formato  
Annals Gen psychiatry_2020.pdf

accesso aperto

Descrizione: Full text editoriale
Tipologia: Full text (versione editoriale)
Licenza: Creative commons
Dimensione 951.7 kB
Formato Adobe PDF
951.7 kB Adobe PDF Visualizza/Apri

I documenti in SFERA sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11392/2423022
Citazioni
  • ???jsp.display-item.citation.pmc??? 11
  • Scopus 23
  • ???jsp.display-item.citation.isi??? 20
social impact